Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Birgitte Vrou Offersen"'
Autor:
Carol Bacchus, Robert P. Coppes, Eric Lartigau, Peter Hoskin, Karin Haustermans, Dietmar Georg, David Thwaites, Michael Baumann, Mechthild Krause, Jens Overgaard, Vincenzo Valentini, Marianne C. Aznar, Eric Deutsch, Birgitte Vrou Offersen, Steffen Löck, Albert J. van der Kogel, Uulke A. van der Heide
Publikováno v:
Radiotherapy and Oncology
Radiotherapy and Oncology, 154, A1-A4. ELSEVIER IRELAND LTD
Aznar, M C, Bacchus, C, Coppes, R P, Deutsch, E, Georg, D, Haustermans, K, Hoskin, P, Krause, M, Lartigau, E F, Löck, S, Offersen, B, Overgaard, J, Thwaites, D I, van der Kogel, A J, van der Heide, U A, Valentini, V & Baumann, M 2021, ' Radiation oncology in the new virtual and digital era ', Radiotherapy and Oncology, vol. 154, pp. A1-A4 . https://doi.org/10.1016/j.radonc.2020.12.031
Radiotherapy and Oncology, 154, A1-A4. ELSEVIER IRELAND LTD
Aznar, M C, Bacchus, C, Coppes, R P, Deutsch, E, Georg, D, Haustermans, K, Hoskin, P, Krause, M, Lartigau, E F, Löck, S, Offersen, B, Overgaard, J, Thwaites, D I, van der Kogel, A J, van der Heide, U A, Valentini, V & Baumann, M 2021, ' Radiation oncology in the new virtual and digital era ', Radiotherapy and Oncology, vol. 154, pp. A1-A4 . https://doi.org/10.1016/j.radonc.2020.12.031
ispartof: RADIOTHERAPY AND ONCOLOGY vol:154 pages:A1-A4 ispartof: location:Ireland status: published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a1646109258c44fdf01f501eaf1672
https://lirias.kuleuven.be/handle/123456789/668521
https://lirias.kuleuven.be/handle/123456789/668521
Autor:
Orit Kaidar-Person, Dirk De Ruysscher, Vered Noy, Liesbeth J. Boersma, Thorsten Kühn, Naama Hermann, Birgitte Vrou Offersen, Philip Poortmans
Publikováno v:
Kaidar-Person, O, Poortmans, P, Offersen, B V, Boersma, L J, de Ruysscher, D, Noy, V, Hermann, N & Kühn, T 2021, ' What are the guidelines for immediate breast reconstruction? ', European Journal of Surgical Oncology, vol. 47, no. 5, pp. 1214-1215 . https://doi.org/10.1016/j.ejso.2020.03.226
European journal of surgical oncology
European Journal of Surgical Oncology, 47(5), 1214-1215. ELSEVIER SCI LTD
European journal of surgical oncology
European Journal of Surgical Oncology, 47(5), 1214-1215. ELSEVIER SCI LTD
Publikováno v:
Radiotherapy and Oncology. 152:101-102
Publikováno v:
Kaidar-Person, O, Offersen, B V & Poortmans, P 2019, ' Should risk-adapted delineation considered de-escalation of therapy? The ESTRO-ACROP radiation therapy guidelines after implant-based immediate reconstruction for early stage breast cancer ', Radiotherapy and Oncology, vol. 141, pp. 327-328 . https://doi.org/10.1016/j.radonc.2019.07.032
Radiother Oncol
Radiother Oncol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::190aafa5bb37105408c8496148066d98
https://pure.au.dk/portal/da/publications/should-riskadapted-delineation-considered-deescalation-of-therapy(0f207c70-b5a0-4514-9c71-10a970471167).html
https://pure.au.dk/portal/da/publications/should-riskadapted-delineation-considered-deescalation-of-therapy(0f207c70-b5a0-4514-9c71-10a970471167).html
Autor:
Birgitte Vrou Offersen, Jens Overgaard
Publikováno v:
Offersen, B V & Overgaard, J 2020, ' Breast cancer radiation therapy ', The Lancet, vol. 396, no. 10262 . https://doi.org/10.1016/S0140-6736(20)32322-9
Autor:
M.S. Thomsen, Carsten Brink, Jonas Westberg, Ebbe Laugaard Lorenzen, E.S. Yates, Ingelise Jensen, Birgitte Vrou Offersen, Martin Berg, Simon L. Krogh
Publikováno v:
Brink, C, Lorenzen, E L, Krogh, S L, Westberg, J, Berg, M, Jensen, I, Thomsen, M S, Yates, E S & Offersen, B V 2018, ' DBCG hypo trial validation of radiotherapy parameters from a national data bank versus manual reporting ', Acta Oncologica, vol. 57, no. 1, pp. 107-112 . https://doi.org/10.1080/0284186X.2017.1406140
INTRODUCTION:The current study evaluates the data quality achievable using a national data bank for reporting radiotherapy parameters relative to the classical manual reporting method of selected parameters.METHODS:The data comparison is based on 152
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cbeaaacba43a10d2a63b90e6f21dfc4
https://pure.au.dk/portal/da/publications/dbcg-hypo-trial-validation-of-radiotherapy-parameters-from-a-national-data-bank-versus-manual-reporting(d15e8d3b-06ac-4cf8-b59e-f741cfb76987).html
https://pure.au.dk/portal/da/publications/dbcg-hypo-trial-validation-of-radiotherapy-parameters-from-a-national-data-bank-versus-manual-reporting(d15e8d3b-06ac-4cf8-b59e-f741cfb76987).html
Autor:
Peer Christiansen, Anne Vibeke Lænkholm, Maj-Britt Jensen, Bent Ejlertsen, Henning T. Mouridsen, Birgitte Vrou Offersen, Niels Kroman
Publikováno v:
Jensen, M-B, Laenkholm, A-V, Offersen, B V, Christiansen, P, Kroman, N, Mouridsen, H T & Ejlertsen, B 2018, ' The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016 ', Acta Oncologica, vol. 57, no. 1, pp. 13-18 . https://doi.org/10.1080/0284186X.2017.1404638
BACKGROUND:Since 40 years, Danish Breast Cancer Cooperative Group (DBCG) has provided comprehensive guidelines for diagnosis and treatment of breast cancer. This population-based analysis aimed to describe the plurality of modifications introduced ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4495310fe193d81c6b2686b947c3a2
https://pure.au.dk/portal/da/publications/the-clinical-database-and-implementation-of-treatment-guidelines-by-the-danish-breast-cancer-cooperative-group-in-20072016(d4dd5b59-92ee-403d-8beb-ab52f91f919a).html
https://pure.au.dk/portal/da/publications/the-clinical-database-and-implementation-of-treatment-guidelines-by-the-danish-breast-cancer-cooperative-group-in-20072016(d4dd5b59-92ee-403d-8beb-ab52f91f919a).html
Autor:
Bent Ejlertsen, Birgitte Vrou Offersen, Peer Christiansen, Anne Vibeke Lænkholm, Ilse Vejborg, Henning T. Mouridsen, Maj-Britt Jensen, Henrik Flyger
Publikováno v:
Mouridsen, H, Christiansen, P, Jensen, M-B, Laenkholm, A-V, Flyger, H, Offersen, B, Vejborg, I & Ejlertsen, B 2018, ' Provision of data from the clinical database and of biological material from the tumor bank of the Danish Breast Cancer Cooperative Group 2008-2017 ', Acta Oncologica, vol. 57, pp. 1-3 . https://doi.org/10.1080/0284186X.2017.1403039
The capability to link health care information across various health care providers (institutions, clinics and professions) is increasingly recognized as an important source for clinical decision m...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::621919661adc0e818fc9adfc930b5628
Publikováno v:
Nielsen, H M & Offersen, B V 2015, ' Regional recurrence after adjuvant breast cancer radiotherapy is not due to insufficient target coverage ', Radiotherapy & Oncology, vol. 114, no. 1, pp. 1-2 . https://doi.org/10.1016/j.radonc.2014.12.012
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13229d9a9355f1958ba05473b7ff36dc
https://pure.au.dk/portal/da/publications/regional-recurrence-after-adjuvant-breast-cancer-radiotherapy-is-not-due-to-insufficient-target-coverage(db6e72d6-16c7-4e50-9369-c88d23721e79).html
https://pure.au.dk/portal/da/publications/regional-recurrence-after-adjuvant-breast-cancer-radiotherapy-is-not-due-to-insufficient-target-coverage(db6e72d6-16c7-4e50-9369-c88d23721e79).html
Autor:
Roger A'Hern, Stefan Michiels, Robert E. Coleman, D. Azria, F. Bonnetain, Gaëtan MacGrogan, Henri Roché, William Jacot, Carine Bellera, Bernard Asselain, David Cameron, Simone Mathoulin-Pélissier, Tanja Cufer, Michael Untch, Hans Wildiers, I. Negreiros, V. Servent, F. Penault Llorca, Suzette Delaloge, G. van Tienhoven, Thomas Filleron, Marc Debled, John Yarnold, Hervé Bonnefoi, P.M. Poortmans, Fernando Schmitt, Nicola S. Russell, Birgitte Vrou Offersen, Judith M Bliss, Joseph Gligorov, Etienne Brain, Florence Dalenc, Fatima Cardoso, E. de Azambuja, Maciej Gutowski, Jan Bogaerts, Sophie Gourgou-Bourgade, L. Dal Lago, Maria João Cardoso, T. S. Dabakuyo-yonli, C. Kirkove, Benoist Chibaudel, J.A. van der Hage, Giancarlo Pruneri, Beat Thürlimann
Publikováno v:
Annals of Oncology, 26, 873-879
Annals of Oncology
Annals of Oncology, 2015, 26 (5), pp.873-879. ⟨10.1093/annonc/mdv106⟩
Gourgou-Bourgade, S, Cameron, D, Poortmans, P, Asselain, B, Azria, D, Cardoso, F, A'Hern, R, Bliss, J, Bogaerts, J, Bonnefoi, H, Brain, E, Cardoso, M J, Chibaudel, B, Coleman, R, Cufer, T, Dal Lago, L, Dalenc, F, De Azambuja, E, Debled, M, Delaloge, S, Filleron, T, Gligorov, J, Gutowski, M, Jacot, W, Kirkove, C, MacGrogan, G, Michiels, S, Negreiros, I, Offersen, B V, Penault Llorca, F, Pruneri, G, Roche, H, Russell, N S, Schmitt, F, Servent, V, Thürlimann, B, Untch, M, van der Hage, J A, van Tienhoven, G, Wildiers, H, Yarnold, J, Bonnetain, F, Mathoulin-Pélissier, S, Bellera, C & Dabakuyo-Yonli, T S 2015, ' Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) ', Annals of Oncology, vol. 26, no. 12, pp. 2505-6 . https://doi.org/10.1093/annonc/mdv478
Annals of Oncology, Elsevier, 2015, 26 (5), pp.873-879. ⟨10.1093/annonc/mdv106⟩
Annals of Oncology, 26, 5, pp. 873-879
Annals of Oncology, Vol. 26, no.5, p. 873-879 (2015)
Annals of Oncology
Annals of Oncology, 2015, 26 (5), pp.873-879. ⟨10.1093/annonc/mdv106⟩
Gourgou-Bourgade, S, Cameron, D, Poortmans, P, Asselain, B, Azria, D, Cardoso, F, A'Hern, R, Bliss, J, Bogaerts, J, Bonnefoi, H, Brain, E, Cardoso, M J, Chibaudel, B, Coleman, R, Cufer, T, Dal Lago, L, Dalenc, F, De Azambuja, E, Debled, M, Delaloge, S, Filleron, T, Gligorov, J, Gutowski, M, Jacot, W, Kirkove, C, MacGrogan, G, Michiels, S, Negreiros, I, Offersen, B V, Penault Llorca, F, Pruneri, G, Roche, H, Russell, N S, Schmitt, F, Servent, V, Thürlimann, B, Untch, M, van der Hage, J A, van Tienhoven, G, Wildiers, H, Yarnold, J, Bonnetain, F, Mathoulin-Pélissier, S, Bellera, C & Dabakuyo-Yonli, T S 2015, ' Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) ', Annals of Oncology, vol. 26, no. 12, pp. 2505-6 . https://doi.org/10.1093/annonc/mdv478
Annals of Oncology, Elsevier, 2015, 26 (5), pp.873-879. ⟨10.1093/annonc/mdv106⟩
Annals of Oncology, 26, 5, pp. 873-879
Annals of Oncology, Vol. 26, no.5, p. 873-879 (2015)
Item does not contain fulltext BACKGROUND: Using surrogate end points for overall survival, such as disease-free survival, is increasingly common in randomized controlled trials. However, the definitions of several of these time-to-event (TTE) end po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90dd1258a723c3b38fcc948457c5e39c
http://hdl.handle.net/2066/155385
http://hdl.handle.net/2066/155385